non-hodgkin's lymphoma regimens - comment on existing regimen
Please complete this form and submit your comments or amendments
Your Details:
Your Name:
Your Email:
Regimen Details:
Non-Hodgkin's Lymphoma Regimen:
Choose One
Alemtuzumab ( v1.0 - Haematology - Peripheral T-cell Lymphoma - Relapse treatment)
Bexarotene ( v1.0 - Haematology - Cutaneous Lymphoma)
Chlorambucil ( v1.0 - Haematology - Extranodal MZL (Gastric) - Primary treatment)
Chlorambucil ( v1.0 - Haematology - Extranodal MZL (Non-gastric) - Primary treatment)
Chlorambucil ( v1.0 - Haematology - Extranodal MZL (Non-gastric) - Relapse treatment)
Chlorambucil ( v1.0 - Haematology - Follicular Lymphoma - Primary treatment)
Chlorambucil ( v1.0 - Haematology - Follicular Lymphoma - Relapse treatment)
Chlorambucil ( v1.0 - Haematology - Mantle Cell Lymphoma - Primary treatment)
Chlorambucil ( v1.0 - Haematology - Marginal Zone Lymphoma - Primary treatment)
Chlorambucil ( v1.0 - Haematology - Marginal Zone Lymphoma - Relapse treatment)
CHOP ( v1.0 - Haematology - DLBCL - Primary treatment)
CHOP ( v1.0 - Haematology - Peripheral T-cell Lymphoma - Primary treatment)
CHOP-R ( v1.0 - Haematology - DLBCL - Primary treatment)
CHOP-R ( v1.0 - Haematology - Extranodal MZL (Gastric) - Recurrence treatment)
CHOP-R ( v1.0 - Haematology - Extranodal MZL (Non-gastric) - Relapse treatment)
CHOP-R ( v1.0 - Haematology - Follicular Lymphoma - Transformed)
CHOP-R ( v1.0 - Haematology - LPNHL - Primary treatment)
CHOP-R ( v1.0 - Haematology - LPNHL - Relapse treatment)
CHOP-R ( v1.0 - Haematology - Mantle Cell Lymphoma - Primary treatment)
CHOP-R ( v1.0 - Haematology - Mantle Cell Lymphoma - Relapse treatment)
CVP-R ( v1.0 - Haematology - Extranodal MZL (Non-gastric) - Relapse treatment)
CVP-R ( v1.0 - Haematology - Follicular Lymphoma - Primary treatment)
CVP-R ( v1.0 - Haematology - Follicular Lymphoma - Relapse treatment)
DHAP-R ( v1.0 - Haematology - DLBCL - Relapse treatment)
DHAP-R ( v1.0 - Haematology - Follicular Lymphoma - Transformed)
DHAP-R ( v1.0 - Haematology - LPNHL - Relapse treatment)
DHAP-R ( v1.0 - Haematology - Peripheral T-cell Lymphoma - Relapse treatment)
ESHAP ( v1.0 - Haematology - Peripheral T-cell Lymphoma - Relapse treatment)
FC (IV) ( v1.0 - Haematology - Mantle Cell Lymphoma - Primary treatment)
FC (IV) ( v1.0 - Haematology - Mantle Cell Lymphoma - Relapse treatment)
FC (Oral) ( v1.0 - Haematology - Mantle Cell Lymphoma - Primary treatment)
FC (Oral) ( v1.0 - Haematology - Mantle Cell Lymphoma - Relapse treatment)
FC-R ( v1.0 - Haematology - Mantle Cell Lymphoma - Primary treatment)
FC-R ( v1.0 - Haematology - Mantle Cell Lymphoma - Relapse treatment)
Fludarabine Oral ( v1.0 - Haematology - Extranodal MZL (Gastric) - Recurrence treatment)
Fludarabine Oral ( v1.0 - Haematology - Extranodal MZL (Non-gastric) - Relapse treatment)
Fludarabine Oral ( v1.0 - Haematology - Follicular Lymphoma - Relapse treatment)
Fludarabine Oral ( v1.0 - Haematology - Marginal Zone Lymphoma - Primary treatment)
Fludarabine Oral ( v1.0 - Haematology - Marginal Zone Lymphoma - Relapse treatment)
Gemcitabine ( v1.0 - Haematology - Peripheral T-cell Lymphoma - Relapse treatment)
GEM-P ( v1.0 - Haematology - Peripheral T-cell Lymphoma - Relapse treatment)
High Dose Methotrexate ( v1.0 - Haematology - DLBCL - Primary treatment)
ICE-R ( v1.0 - Haematology - DLBCL - Relapse treatment)
ICE-R ( v1.0 - Haematology - Follicular Lymphoma - Transformed)
ICE-R ( v1.0 - Haematology - LPNHL - Relapse treatment)
ICE-R ( v1.0 - Haematology - Peripheral T-cell Lymphoma - Relapse treatment)
IDARAM ( v1.0 - Haematology - DLBCL - Primary treatment)
In-patient Ifosfamide/Mitozantrone ( v1.0 - Haematology - Peripheral T-cell Lymphoma - Relapse treatment)
R-CODOX-M no CNS involvement ( v1.0 - Haematology - Burkitt Lymphoma - Primary treatment)
R-CODOX-M with CNS involvement ( v1.0 - Haematology - Burkitt Lymphoma - Primary treatment)
R-Hyper-CVAD Course A ( v1.0 - Haematology - Mantle Cell Lymphoma - Primary treatment)
R-Hyper-CVAD Course A ( v1.0 - Haematology - Mantle Cell Lymphoma - Relapse treatment)
R-Hyper-CVAD Course B ( v1.0 - Haematology - Mantle Cell Lymphoma - Primary treatment)
R-Hyper-CVAD Course B ( v1.0 - Haematology - Mantle Cell Lymphoma - Relapse treatment)
Rituximab ( v1.0 - Haematology - Extranodal MZL (Gastric) - Recurrence treatment)
Rituximab ( v1.0 - Haematology - Extranodal MZL (Non-gastric) - Relapse treatment)
Rituximab ( v1.0 - Haematology - Follicular Lymphoma - Relapse treatment)
Rituximab ( v1.0 - Haematology - Marginal Zone Lymphoma - Primary treatment)
Rituximab - Maintenance ( v1.0 - Haematology - Follicular Lymphoma - Relapse treatment)
Rituximab - Maintenance ( v1.0 - Haematology - Follicular Lymphoma - Transformed)
R-IVAC no CNS involvement ( v1.0 - Haematology - Burkitt Lymphoma - Primary treatment)
R-IVAC with CNS involvement ( v1.0 - Haematology - Burkitt Lymphoma - Primary treatment)
Thalidomide ( v1.0 - Haematology - Peripheral T-cell Lymphoma - Relapse treatment)
Zevalin ( v1.0 - Haematology - Follicular Lymphoma - Relapse treatment)
Zevalin ( v1.0 - Haematology - Follicular Lymphoma - Transformed)
Comments:
Chemotherapy
Haematology regimens
Non-Hodgkin's Lymphoma regimens
